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Background: Therapeutic strategies aiming to reduce ischemia/reperfusion injury by conditioning tissue tolerance
against ischemia appear attractive not only from a scientific perspective, but also in clinics. Although previous
studies indicate that remote ischemic intermittent preconditioning (RIPC) is a systemic phenomenon, only a few
studies have focused on the elucidation of its mechanisms of action especially in the clinical setting. Therefore, the
aim of this study is to evaluate the acute microcirculatory effects of remote ischemic preconditioning on a distinct
cutaneous location at the lower extremity which is typically used as a harvesting site for free flap reconstructive
surgery in a human in-vivo setting.
Methods: Microcirculatory data of 27 healthy subjects (25 males, age 24 ± 4 years, BMI 23.3) were evaluated
continuously at the anterolateral aspect of the left thigh during RIPC using combined Laser-Doppler and
photospectrometry (Oxygen-to-see, Lea Medizintechnik, Germany). After baseline microcirculatory measurement,
remote ischemia was induced using a tourniquet on the contralateral upper arm for three cycles of 5 min.
Results: After RIPC, tissue oxygen saturation and capillary blood flow increased up to 29% and 35% during the
third reperfusion phase versus baseline measurement, respectively (both p = 0.001). Postcapillary venous filling
pressure decreased statistically significant by 16% during second reperfusion phase (p = 0.028).
Conclusion: Remote intermittent ischemic preconditioning affects cutaneous tissue oxygen saturation, arterial
capillary blood flow and postcapillary venous filling pressure at a remote cutaneous location of the lower
extremity. To what extent remote preconditioning might ameliorate reperfusion injury in soft tissue trauma or free
flap transplantation further clinical trials have to evaluate.
Trial registration: ClinicalTrials.gov: NCT01235286
Keywords: Remote ischemic preconditioning, cutaneous microcirculation, free flap, soft tissue
Background
In several medical specialties, reduction of ischemia/reper-
fusion injury is a major topic. In trauma surgery, soft tis-
sue defects after trauma due to accidents or due to
operative trauma are quite common. In plastic and recon-
structive surgery, on the other hand, soft tissue coverage is
commonly performed using local or free flaps. Despite
remarkable progress in surgical techniques and postopera-
tive free flap monitoring devices over the last decades, free
flap surgery is still associated with a significant morbidity.
Current scientific literature reports a total loss rate of
microsurgically transferred free flaps in one to five percent
[1,2]. The main reasons are either persistent postoperative
ischemia and hypoxia or transient ischemia associated
with ischemia reperfusion injury [3]. Reducing or prevent-
ing soft tissue or free flap necrosis by conditioning tissue
tolerance against ischemia is paramount in development
of new treatment strategies. Current scientific literature
demonstrates a possible induction of ischemic tolerance of
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any medium, provided the original work is properly cited.several tissues by application of stressors including sub-
lethal ischemia, hyperthermia, hypothermia, drugs and
growth factors [4,5].
Applying brief periods of sublethal ischaemia to the tar-
get tissue with subsequent reperfusion is a simple method
of ischemic tolerance induction, which is called ischemic
preconditioning (IP). The aim of IP is to increase the resis-
tance of the tissue against the subsequent deleterious
ischemia reperfusion injury [4]. Nitric oxide (NO) as well
as adenosine release has been shown to regulate endothe-
lial function and increase blood flow in ischemic precondi-
tioning settings [6]. However, direct IP produces trauma to
major vessels and direct stress to the target organ.
Remote ischemic preconditioning (RIPC) is a further
development of IP where ischemia followed by reperfusion
of one organ is believed to protect remote organs either
due to a systemic release of biochemical messengers in the
circulation or activation of nerve pathways, also resulting
in a secondary release of messengers that have a protective
effect. This protects the target tissue without trauma to
major vessels or direct stress to the target organ. In animal
models, RIPC performed at the limb, gut, mesenteric, kid-
ney or skeletal muscle reduced myocardial infarct size [7].
Furthermore, ischemic preconditioning has already been
shown to be effective in flap surgery, demonstrated by an
ameliorated survival of tissue in a porcine latissimus dorsi
flap model [8].
A considerable number of experimental studies con-
firmed successful IP in flap surgery [9-11]. Since the intro-
duction of IP to flap surgery, various procedures have
been discussed such as the ideal time point of IP applica-
tion, the duration of the IP cycle and the total number of
cycles to apply.
Although the efficiency of IP has been demonstrated
numerously in experimental in-vivo models, ‘classical’ IP
has rarely been used in the clinical setting to target
ischaemia- and reperfusion-associated complications
[12].
A recent clinical trial among patients suffering from myo-
cardial infarction demonstrated an increased myocardial
salvage after prehospital remote ischaemic conditioning. To
date, no scientific investigation has evaluated the acute
microcirculatory effects of RIPC on cutaneous soft tissue in
order to potentially attenuate the ischemia-reperfusion-
injury during soft tissue traumatization or free flap trans-
plantation in a perioperative clinical setting. Therefore, we
hypothesized that intermittent remote ischemic precondi-
tioning is able to immediately effect cutaneous microcircu-
lation at a distinct cutaneous location at the lower
extremity at a potential adipocutaneous free flap location
Methods
The research was carried out in accordance with the
Declaration of Helsinki (2000) of the World Medical
Association and was approved by the Institutional
Ethics Committee in October 2010. The study was
registered at ClinicalTrials.gov with the identifier num-
ber NCT01235286.
Written consent was obtained from each study subject
prior to commencement of the investigation.
The study is reported according to the STROBE-
guidelines (Strengthening the Reporting of Observa-
tional Studies in Epidemiology) [13].
Study design and setting
The study was designed as a prospective, controlled
cohort study.
Data assessment was performed at the Department of
Plastic, Hand and Reconstructive Surgery, Medical
School Hannover, Germany between May and September
2010 using combined Laser-Doppler and photospectro-
metry (Oxygen-to-see, Lea Medizintechnik, Germany)
which is regularly used for free flap microcirculatory
monitoring at our department to determine postoperative
free flap microcirculation. In order to determine changes
of microcirculation resulting from remote ischemic pre-
conditioning at a representative location for soft tissue
traumatization and free flap transfer, we chose a distinct
area for microcirculatory assessment at the anterolateral
aspect of the thigh in the means of an ALT- (anterolat-
eral thigh-) flap. A standardized location for microcircu-
latory assessment was determined on the left leg of each
participant between the proximal and distal third of a
drawn line between the anterior superior iliac spine and
the lateral aspect of the Patella.
The healthy subjects had to rest before starting data
assessment in a horizontal position for 15 minutes. The
probe was taped on the left upper leg in a standardized
manner after localizing the measuring point. A blood
pressure cuff was applied on the contralateral upper arm.
Baseline data was assessed over 5 minutes before starting
remote ischemia. Three circles of a five minute ischemia
were applied at the contralateral right upper arm at
suprasystolic levels. Parameters of microcirculation were
assessed continuously over time. Microcirculation during
the reperfusion phase was ascertained over 10 minutes
after first and second remote ischemia and 15 minutes
after the third remote ischemia.
Participants
Study population and recruitment
Eligibility criteria were healthy male and female subjects
aged 18 to 35 years. Measurements were performed at the
Department of Plastic, Hand and Reconstructive Surgery,
Medical School Hannover, Germany. Healthy subjects
were recruited from the Medical School Hannover.
Exclusion criteria were soft tissue inflammation or
osteomyelitis, peripheral arterial occlusive disease,
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dysfunction, arterial hypotension and any type of
vasoactive medication, i.e. ß-blockers, calcium channel
blockers, nitroglycerin or equal.
The study population was a consecutive series of par-
ticipants defined by the aforementioned selection
criteria.
Variables
Determination of vital parameters of microcirculation
The determination of hemoglobin and the principle of
blood flow measurement are combined in the O2C sys-
tem. The optical method for measuring both, blood flow
by Laser-Doppler technique and hemoglobin oxygenation
and hemoglobin concentration in tissue by spectrometric
techniques, has been described in detail elsewhere [14].
The local oxygen supply parameters, blood flow, oxygen
saturation of hemoglobin, and the relative postcapillary
venous filling pressures were recorded by an optical fiber
probe. The fiber probe incorporates both the laser Doppler
method and the broadband light spectrometry technique.
The probe we used assessed data in 2 and 8 millimeters
depth of the free flap regarding:
￿ capillary blood flow [arbitrary units AU]
￿ tissue oxygen saturation [%]
￿ relative postcapillary venous filling pressure [AU]
Bias
Structural measurement bias was avoided by standardisa-
tion of environmental factors during assessment of micro-
circulatory data, i.e. assessment by the same examiner,
uniform subject’s position during measurement, ambient
light and temperature standardisation. Artefacts from
microcirculatory measurements were tried to be avoided
by fixation of the measurement probe on the same distinct
location at the left upper leg of each subject.
The outcome variable selection bias was avoided by pre-
senting all assessed microcirculatory variables in the paper
that represent separate factors of microcirculation. Also,
insignificant measures were presented. Literature retrieval
biases were prevented by independent literature research
through the National Library of Medicine. Funding bias
was eliminated by disclosure of any financial support of
any author of the paper.
Statistical analysis
Repeated measures ANOVA and a Bonferroni-Holm-
procedure as standard in multiple t-tests of statistical
analysis were applied for comparison of baseline pre-
ischemic vs. post-ischemic microcirculatory changes. A
p-value less than 0.05 was considered to indicate statisti-
cal significance. The SPSS statistical software package




A total number of 27 healthy subjects (25 males, 2
females) were enrolled in the evaluation of microcircula-
tory effects of remote ischemic preconditioning at the
Department of Plastic, Hand and Reconstructive Surgery,
Medical School Hannover, Germany.
Mean subject’s age was 24 ± 4 years. Mean body-
mass-index was 23.3 ± 3.0. All subjects were healthy
non-smokers without any history of arterial hyperten-
sion, diabetes mellitus or vascular disease. Two thirds of




Cutaneous capillary blood flow increased by 16% during
the first reperfusion phase at the anterolateral thigh, which
reached statistical significance during the first minute after
the first remote ischemia (126 ± 71 Arbitrary Units [AU]
vs. 146 ± 67 AU; p = 0.001; Figure 1).
After ascending undulation of the microcirculatory
blood flow during second and third remote reperfusion,
the peak blood flow was reached straight after the third
remote ischemia with an increase versus baseline measure-
ment by 35% (126 ± 71 AU vs. 170 ± 73 AU; p = 0.001).
Postcapillary venous filling pressure
Cutaneous postcapillary filling pressure at the anterolateral
thigh decreased statistically significant 5 minutes after the
second remote ischemia by 16% versus baseline (48 ± 19
AU vs. 41 ± 17 AU; p = 0.028; Figure 2).
Tissue oxygen saturation
Tissue oxygen saturation assessed at the anterolateral
thigh increased three minutes after remote ischemia
reaching statistical significance eleven minutes after the
second remote ischemia with an increase by 19% versus
baseline measurement (46 ± 10% vs. 55 ± 12%; p = 0.021;
Figure 3). The highest tissue oxygen saturation was
detected 10 minutes after the third remote ischemia show-
ing an increased oxygen saturation by 29% versus baseline
measurement (46 ± 10% vs. 59 ± 8%; p = 0.001).
Discussion
Key results
We hypothesized that remote ischemic preconditioning
(RIPC) is able to immediately affect cutaneous microcircu-
lation at a potential fasciocutaneous free flap location at
the anterolateral thigh (ALT-) region in a human in-vivo
setting. This prospective controlled clinical study could
demonstrate a significant increase of cutaneous oxygen
saturation at the anterolateral thigh (ALT) skin territory, a
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as well as a statistical significant decrease of the postcapil-
lary filling pressure as a marker of venous stasis during
reperfusion phases immediately after RIPC. Therefore, our
primary hypothesis was supported. These results should
be discussed in detail.
In trauma and reconstructive surgery, tissue survival is
paramount. In spite of tremendous progress in surgical
techniques notably in reconstructive microsurgery, soft
tissue still is endangered by both the lack of reoxygena-
tion and the reoxygenation-associated inflammation due
to reperfusion injury, especially in soft tissue trauma as
Figure 1 Capillary blood flow [AU] with significant changes during ischemia- and reperfusion-phases.
Figure 2 Postcapillary venous filling pressure [AU] with significant changes during ischemia- and reperfusion-phases.
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deleterious effects of ischemia and reperfusion injury,
several methods of ischemia tolerance induction were
developed including sublethal ischemia, hyperthermia,
hypothermia, drugs and growth factors [4,5].
In plastic and reconstructive surgery, effects of ischemic
preconditioning were also evaluated in free flap transplan-
tation leading to a significant reduction of muscle flap
necrosis supposedly by increasing the critical ischemia
time of the free flap’s soft tissue.
With the aim of reducing the number of additional pro-
cedures and the invasiveness of the individual precondi-
tioning measures, remote ischemic preconditioning (RIPC)
was introduced. The ameliorating effect of RIPC was
attributed to regulation of endothelial protection, whereas
other studies about the mechanisms of preconditioning
effects on muscle and musculocutaneous flaps disclosed a
decrease of capillary no-reflow, attenuation of arteriolar
vasospasm and an increase of blood flow response
[11,16-18]. Furthermore, if ischemic preconditioning is
applied directly before critical soft tissue ischemia, it pro-
tects both against the leukocytic inflammatory reperfusion
injury and against microcirculatory dysfunction. On the
other hand, ischemic preconditioning performed 24 hours
or more before critical soft tissue ischemia acts anti-
inflammatory, but is not capable of improving the micro-
circulation [19]. The short-term microcirculatory assess-
ment in our study was performed straight after remote
ischemia to detect acute cutaneous microcirculatory
effects of remote ischemic preconditioning. The intention
of this study was not to evaluate the protective effects of
RIPC on soft tissue in general over days after trauma or
operation, but to detect whether RIPC has effects on cuta-
neous microcirculation and if so what kind of effects these
might be. No other study before has demonstrated micro-
circulatory effects of RIPC on skin which should also be
considered to be an important body organ that must be
protected against ischemia in several settings.
Although it is generally accepted that IP increases flap
survival by enhancing microvascular perfusion, the mole-
cular and microcirculatory mechanisms are still not com-
pletely understood. The noninvasive application of a
tourniquet at the hindlimb to induce IP was introduced by
Kuentscher et al. and demonstrated to be as effective as
the invasive clamping of the flap’s pedicle itself, including
both adipocutaneous and muscle flaps [20].
Recently, remote ischemic preconditioning demon-
strated a modulation of hepatic microcirculation with con-
secutive reduction of the effects of ischemic reperfusion
injury in an in-vivo animal model. RIPC in that setting sig-
nificantly increased red blood cell velocity, sinusoidal flow
and sinusoidal perfusion along with decreased neutrophil
adhesion and cell death. For remote preconditioning the
tourniquet was tightened around the limb until no flow
was detected. The procedure involved 5 minutes of ische-
mia followed by 5 minutes of reperfusion. This was
repeated four times [21]. Regarding myocardial perfusion,
Hooele et al. could not find an effect of RIPC on coronary
microvascular resistance or coronary flow in humans [22].
Nevertheless, Thielmann et al. found that myocardial
injury after coronary artery bypass grafting was reduced by
RIPC [23]. Zimmermann et al. demonstrated RIPC as
Figure 3 Tissue oxygen saturation [%] with significant changes during ischemia- and reperfusion-phases.
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cardiac surgery. In that study remote ischemic precondi-
tioning was applied by an automated thigh tourniquet
consisting of three 5-minute intervals of lower extremity
ischemia separated by 5-minute intervals of reperfusion.
Within 48 hours after surgery there was a significant both
absolute and relative risk reduction due to preconditioning
[24]. Another recent trial found no evidence that remote
ischemic preconditioning provided protection of kidney
function in children undergoing operation for complex
congenital heart disease. Four cycles of five minutes RIPC
were applied in that study [25].
The clinical and experimental data about RIPC in cur-
rent literature remains confusing. An equal microcircula-
tory effect of RIPC on different kinds of tissue obviously is
not mandatory demonstrated in several studies. A dose
effect dependency can still not be included in RIPC
because of the fact that there is still a non-equivalent effect
apparent in different trials with identical dosages of RIPC.
The main reason for this heterogeneous scientific data
could be the indisputable heterogeneity of clinical studies
concerning with RIPC, especially in terms of methodology
and cohorts [26]. Thus, basic scientific research on RIPC
is mandatory and must include investigations on healthy
cohorts. For this reason, we included only young, healthy
subjects in our study and focused our investigation on
immediate and short-term effects of RIPC on a currently
scientifically non-investigated body area.
Current scientific data demonstrate that three cycles of
IP are significantly superior to one or two cycles, regard-
less of whether the cycles were 5 min or 10 min [27].
According to that current literature, remote ischemia in
our study was applied at the contralateral upper arm
including five minutes of ischemia with ten and finally fif-
teen minutes of reperfusion over three circles leading to
an increase of cutaneous oxygen saturation at the antero-
lateral thigh skin territory, a significant increase of the
capillary blood flow as well as a statistical significant
decrease of the postcapillary filling pressure as a marker of
venous stasis.
As our study elucidated the short term results of RIPC
and documented the beneficial effect of the intermittent,
repetitive component of RIPC on microcirculation, further
studies should now focus on intermediate and long term
effects of RIPC on cutaneous microcirculation. Another
field of application of RIPC should also be part of further
investigations calling muscular microcirculation as ische-
mia of muscle does not necessarily lead to muscle necro-
sis, but can lead to progressive microvascular dysfunction
at an early stage with consecutive microcirculatory impair-
ment as a vicious circle up to a compartment syndrome
[28]. Therefore, an increase of cutaneous oxygen satura-
tion and capillary blood flow as well as a decrease of
venous stasis as immediate effects of RIPC, which we
demonstrated in our study, might also be beneficial in
reoxygenation-associated inflammation due to reperfusion
injury in muscular trauma or surgery.
Limitations
This study enrolled 27 healthy subjects for microcircula-
tory assessment of RIPC. In spite of the cohort size, statisti-
cal analysis found significant changes of microcirculation.
Nevertheless, further studies have to evaluate the correla-
tion of the microcirculatory parameters and RIPC in a clin-
ical setting before and after extended soft tissue
traumatization or elective free flap transplantation.
Conclusion
Remote ischemic preconditioning effects cutaneous tissue
oxygen saturation, arterial capillary blood flow and postca-
pillary venous filling pressure at a distinct location of the
lower extremity. Although, current scientific literature
indicates that remote preconditioning is a systemic phe-
nomenon, only a few studies have focused on the elucida-
tion of its mechanisms of action. To what extent early and
late remote preconditioning might influence the reperfu-
sion injury of free flap transplantation, further clinical
trials have to evaluate both in the means of microcircula-
tory assessment and clinical assessment of soft tissue
necrosis due to traumatization or partial or total flap loss
in free flap transplantation as end points of these studies.
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